Bio- and Nanomaterials for Tumor Therapy and Cancer Drug Delivery
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Cancer Therapies".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 5
Special Issue Editors
Interests: drug delivery; block copolymers; engineered live biotherapeutics; polymeric micelles; gene delivery; bacteria therapy; smart materials; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: tumor therapy; oncolytic virus; nanomedicine; IBD; hydrogel
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tumor immunotherapy has emerged as a transformative modality in oncology; however, its clinical efficacy remains limited by the immunosuppressive tumor microenvironment, insufficient immune activation, and poor drug penetration. To overcome these challenges, both oncolytic microbes (including bacteria and viruses) and nanoparticle-based platforms have garnered increasing attention for their ability to stimulate robust anti-tumor immune responses. Oncolytic bacteria and viruses offer unique tumor-targeting capabilities and can directly induce immunogenic tumor cell death while remodeling the immune landscape. Meanwhile, nanomaterials provide versatile tools for targeted delivery of immunomodulators, controlled release, and enhanced accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect or active targeting strategies.
This Special Issue aims to showcase cutting-edge advances in oncolytic microbial therapy and nanotechnology-enabled immunotherapy, with a focus on their individual roles in enhancing anti-tumor immune responses. Both original research and comprehensive review articles are welcome.
Topics of interest include, but are not limited to, the following:
- Oncolytic bacteria and viruses for tumor-specific immune activation;
- Immune modulation by bacterial or viral components (e.g., PAMPs, cytokines);
- Nanoparticle-based delivery of immune checkpoint inhibitors or adjuvants;
- Nanovaccines for cancer immunotherapy;
- Remodeling of the tumor immune microenvironment via nanomaterials or microbes;
- Combination strategies of microbial therapy or nanomedicine with radiotherapy, chemotherapy, or ICIs.
This Special Issue welcomes contributions that provide new insights and tools to advance the next generation of tumor immunotherapeutic strategies.
Dr. Zhiting Cao
Dr. Jilong Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor immunotherapy
- targeted delivery
- controlled release
- oncolytic microbes
- nanoparticles
- nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
